INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

INCYTE CORP

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 28, 2026

$113.25+0.18 (+0.16%)

Close on Oct 19, 2026

Margins

Share of revenue, fiscal years 2011 to 2025

92.8%−2.3 pts over 5 years

29.5%+39.4 pts over 5 years

25.0%+36.1 pts over 5 years

Compound annual growth to fiscal 2025

Per year	1 year	3 years	5 years	10 years
Revenue	+21.2%	+14.8%	+14.0%	+21.2%
Gross profit	+21.4%	+14.4%	+13.5%	+20.7%
Operating income	+2368.6%	+37.8%	–	+40.5%
Net income	+3845.0%	+55.7%	–	–
EPS, diluted	+4173.3%	+61.6%	–	+71.0%

10 fiscal years. Hover a measure to see how it is calculated.

Measure	FY2016	FY2020	FY2025
Return on equity	35.3%	-11.4%	29.9%
Return on assets	7.9%	-8.5%	20.7%
Current ratio	3.64	3.74	3.32
Interest coverage	3.7×	-121.3×	623.9×
Inventory turnover	19.8×	9.4×	4.7×
Capex to revenue	10.9%	7.0%	–
Diluted shares	194M	218M	201M

Return on equity split into margin, efficiency and leverage

Net margin25.0%

Asset turnover0.83×

Equity multiplier1.44×

Return on equity, FY202529.9%

Fiscal year	Net margin	Asset turnover	Equity multiplier	Return on equity
FY2025	25.0%	0.83×	1.44×	29.9%
FY2024	0.8%	0.69×	1.42×	0.8%
FY2023	16.2%	0.59×	1.32×	12.5%
FY2022	10.0%	0.63×	1.32×	8.4%
FY2021	31.8%	0.70×	1.33×	29.7%
FY2020	-11.1%	0.76×	1.34×	-11.4%
FY2019	20.7%	0.71×	1.34×	19.8%
FY2018	5.8%	0.76×	1.39×	6.2%
FY2017	-20.4%	0.78×	1.92×	-30.5%
FY2016	9.4%	0.84×	4.48×	35.3%